Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
367 Ergebnisse
| VY8B7W | Edwards Lifesciences Corp./OS/Call [105]/VONT | - | - | 105,000 | call | Edwards Lifesciences Corp. | - | 37,645 % | 0,237 | -0,014 | 7,943 | 18.12.2026 | 0,100 | Vontobel | ||
| MM7M65 |  | Edwards Lifesciences Corp./OS/Call [107,5]/MS | - | - | 107,500 | call | Edwards Lifesciences Corp. | - | 48,540 % | 0,285 | -0,020 | 6,020 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MM7M66 | | Edwards Lifesciences Corp./OS/Call [107,5]/MS | - | - | 107,500 | call | Edwards Lifesciences Corp. | - | 45,365 % | 0,399 | -0,015 | 4,089 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM7M67 | | Edwards Lifesciences Corp./OS/Call [107,5]/MS | - | - | 107,500 | call | Edwards Lifesciences Corp. | - | 61,880 % | 0,203 | -0,032 | 8,098 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN034J | | Edwards Lifesciences Corp./OS/Call [107,5]/MS | - | - | 107,500 | call | Edwards Lifesciences Corp. | - | 51,925 % | 0,500 | -0,014 | 2,858 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN8MAG | | Edwards Lifesciences Corp./OS/Call [107,5]/MS | - | - | 107,500 | call | Edwards Lifesciences Corp. | - | 45,876 % | 0,348 | -0,017 | 4,842 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR3CRR | | Edwards Lifesciences Corp./OS/Call [107,5]/MS | - | - | 107,500 | call | Edwards Lifesciences Corp. | - | 60,817 % | 0,587 | -0,014 | 2,172 | 16.06.2028 | 0,100 | Morgan Stanley | |
| PK34T6 | | Edwards Lifesciences Corp./OS/Call [110]/BNP | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 36,276 % | 0,170 | -0,011 | 8,948 | 18.12.2026 | 0,100 | BNP Paribas | |
| PK34T4 | | Edwards Lifesciences Corp./OS/Call [110]/BNP | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 59,800 % | 0,166 | -0,027 | 8,767 | 18.09.2026 | 0,100 | BNP Paribas | |
| PK5Y1X | | Edwards Lifesciences Corp./OS/Call [110]/BNP | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 35,857 % | 0,197 | -0,011 | 8,071 | 15.01.2027 | 0,100 | BNP Paribas | |
| JE0PTN | Edwards Lifesciences Corp./OS/Call [110]/JPMD | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 36,030 % | 0,250 | -0,011 | 6,578 | 19.03.2027 | 0,100 | JP Morgan | ||
| JE6G2G | Edwards Lifesciences Corp./OS/Call [110]/JPMD | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 37,700 % | 0,146 | -0,011 | 9,793 | 20.11.2026 | 0,100 | JP Morgan | ||
| JY1SSZ | Edwards Lifesciences Corp./OS/Call [110]/JPMD | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 34,342 % | 0,156 | -0,010 | 9,595 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY02W7 | Edwards Lifesciences Corp./OS/Call [110]/JPMD | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 33,356 % | 0,179 | -0,010 | 8,822 | 15.01.2027 | 0,100 | JP Morgan | ||
| MJ6QBT | | Edwards Lifesciences Corp./OS/Call [110]/MS | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 49,744 % | 0,268 | -0,020 | 6,005 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9KWV | | Edwards Lifesciences Corp./OS/Call [110]/MS | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 46,113 % | 0,383 | -0,015 | 4,098 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM5HM1 | | Edwards Lifesciences Corp./OS/Call [110]/MS | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 64,946 % | 0,190 | -0,032 | 7,882 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN034K | | Edwards Lifesciences Corp./OS/Call [110]/MS | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 51,779 % | 0,487 | -0,014 | 2,899 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN6D0V | | Edwards Lifesciences Corp./OS/Call [110]/MS | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 46,304 % | 0,331 | -0,016 | 4,890 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR3CRS | | Edwards Lifesciences Corp./OS/Call [110]/MS | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 60,220 % | 0,574 | -0,014 | 2,207 | 16.06.2028 | 0,100 | Morgan Stanley | |
| VH9UAQ | | Edwards Lifesciences Corp./OS/Call [110]/VONT | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | - | - | - | - | 15.01.2027 | 0,100 | Vontobel | |
| VJ67P4 | | Edwards Lifesciences Corp./OS/Call [110]/VONT | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 38,320 % | 0,186 | -0,012 | 8,328 | 18.12.2026 | 0,100 | Vontobel | |
| VY50N0 | | Edwards Lifesciences Corp./OS/Call [110]/VONT | - | - | 110,000 | call | Edwards Lifesciences Corp. | - | 43,777 % | 0,081 | -0,012 | 13,529 | 18.09.2026 | 0,100 | Vontobel | |
| MR170B | | Edwards Lifesciences Corp./OS/Call [112,5]/MS | - | - | 112,500 | call | Edwards Lifesciences Corp. | - | 52,496 % | 0,475 | -0,014 | 2,899 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MR1709 | | Edwards Lifesciences Corp./OS/Call [112,5]/MS | - | - | 112,500 | call | Edwards Lifesciences Corp. | - | 50,766 % | 0,252 | -0,019 | 6,008 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MR170A | | Edwards Lifesciences Corp./OS/Call [112,5]/MS | - | - | 112,500 | call | Edwards Lifesciences Corp. | - | 47,618 % | 0,316 | -0,016 | 4,851 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR170C | | Edwards Lifesciences Corp./OS/Call [112,5]/MS | - | - | 112,500 | call | Edwards Lifesciences Corp. | - | 46,364 % | 0,366 | -0,015 | 4,149 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MR3BVY | | Edwards Lifesciences Corp./OS/Call [112,5]/MS | - | - | 112,500 | call | Edwards Lifesciences Corp. | - | 60,265 % | 0,564 | -0,014 | 2,225 | 16.06.2028 | 0,100 | Morgan Stanley | |
| JY1ST3 | Edwards Lifesciences Corp./OS/Call [115]/JPMD | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 35,364 % | 0,118 | -0,008 | 9,911 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY02W8 | Edwards Lifesciences Corp./OS/Call [115]/JPMD | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 34,214 % | 0,136 | -0,008 | 9,144 | 15.01.2027 | 0,100 | JP Morgan | ||
| JY18GV | Edwards Lifesciences Corp./OS/Call [115]/JPMD | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 36,623 % | 0,212 | -0,010 | 6,786 | 19.03.2027 | 0,100 | JP Morgan | ||
| MK74DU | | Edwards Lifesciences Corp./OS/Call [115]/MS | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 52,829 % | 0,240 | -0,019 | 5,873 | 18.12.2026 | 0,100 | Morgan Stanley | |
| MK9KWW | | Edwards Lifesciences Corp./OS/Call [115]/MS | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 46,907 % | 0,351 | -0,015 | 4,171 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MM5HM2 | | Edwards Lifesciences Corp./OS/Call [115]/MS | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 70,622 % | 0,174 | -0,033 | 7,483 | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN034L | | Edwards Lifesciences Corp./OS/Call [115]/MS | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 52,263 % | 0,460 | -0,014 | 2,949 | 17.12.2027 | 0,100 | Morgan Stanley | |
| MN6D0W | | Edwards Lifesciences Corp./OS/Call [115]/MS | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 48,093 % | 0,299 | -0,016 | 4,896 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR3BVZ | | Edwards Lifesciences Corp./OS/Call [115]/MS | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 60,991 % | 0,557 | -0,014 | 2,221 | 16.06.2028 | 0,100 | Morgan Stanley | |
| VY8B7X | Edwards Lifesciences Corp./OS/Call [115]/VONT | - | - | 115,000 | call | Edwards Lifesciences Corp. | - | 39,032 % | 0,147 | -0,011 | 8,658 | 18.12.2026 | 0,100 | Vontobel | ||
| MR3BW0 | | Edwards Lifesciences Corp./OS/Call [117,5]/MS | - | - | 117,500 | call | Edwards Lifesciences Corp. | - | 61,379 % | 0,548 | -0,014 | 2,229 | 16.06.2028 | 0,100 | Morgan Stanley | |
| MR3CRV | | Edwards Lifesciences Corp./OS/Call [117,5]/MS | - | - | 117,500 | call | Edwards Lifesciences Corp. | - | 49,398 % | 0,289 | -0,016 | 4,839 | 19.03.2027 | 0,100 | Morgan Stanley | |
| MR3CRT | | Edwards Lifesciences Corp./OS/Call [117,5]/MS | - | - | 117,500 | call | Edwards Lifesciences Corp. | - | 47,208 % | 0,336 | -0,015 | 4,208 | 17.06.2027 | 0,100 | Morgan Stanley | |
| MR3CRU | | Edwards Lifesciences Corp./OS/Call [117,5]/MS | - | - | 117,500 | call | Edwards Lifesciences Corp. | - | 52,970 % | 0,450 | -0,014 | 2,943 | 17.12.2027 | 0,100 | Morgan Stanley | |
| PK34T5 | | Edwards Lifesciences Corp./OS/Call [120]/BNP | - | - | 120,000 | call | Edwards Lifesciences Corp. | - | 43,978 % | 0,147 | -0,012 | 7,777 | 18.12.2026 | 0,100 | BNP Paribas | |
| PK34T9 | | Edwards Lifesciences Corp./OS/Call [120]/BNP | - | - | 120,000 | call | Edwards Lifesciences Corp. | - | 40,145 % | 0,148 | -0,010 | 7,804 | 15.01.2027 | 0,100 | BNP Paribas | |
| PK34UB | | Edwards Lifesciences Corp./OS/Call [120]/BNP | - | - | 120,000 | call | Edwards Lifesciences Corp. | - | 38,229 % | 0,334 | -0,010 | 4,183 | 17.12.2027 | 0,100 | BNP Paribas | |
| PK34UA | | Edwards Lifesciences Corp./OS/Call [120]/BNP | - | - | 120,000 | call | Edwards Lifesciences Corp. | - | 37,353 % | 0,179 | -0,009 | 6,964 | 19.03.2027 | 0,100 | BNP Paribas | |
| PK507C | | Edwards Lifesciences Corp./OS/Call [120]/BNP | - | - | 120,000 | call | Edwards Lifesciences Corp. | - | 37,955 % | 0,346 | -0,010 | 4,052 | 21.01.2028 | 0,100 | BNP Paribas | |
| PK512S | | Edwards Lifesciences Corp./OS/Call [120]/BNP | - | - | 120,000 | call | Edwards Lifesciences Corp. | - | 38,918 % | 0,374 | -0,010 | 3,728 | 17.03.2028 | 0,100 | BNP Paribas | |
| JY1ST0 | Edwards Lifesciences Corp./OS/Call [120]/JPMD | - | - | 120,000 | call | Edwards Lifesciences Corp. | - | 36,842 % | 0,096 | -0,007 | 9,946 | 18.12.2026 | 0,100 | JP Morgan | ||
| JY02W6 | Edwards Lifesciences Corp./OS/Call [120]/JPMD | - | - | 120,000 | call | Edwards Lifesciences Corp. | - | 36,185 % | 0,117 | -0,008 | 8,996 | 15.01.2027 | 0,100 | JP Morgan |